April 2, 2024
New Aculys Pharma CEO Hidemasa Tanigaki Aculys Pharma, a Tokyo-based clinical-stage biopharma specializing in neurological disorders, said on April 1 that 30-year industry veteran Hidemasa Tanigaki has been appointed its new CEO, effective March 29. Mr Tanigaki is taking over...read more